Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 961-970

  Suszynski, T M ^a   Gillingham, K J ^a   Rizzari, M D ^a   Dunn, T B ^a   Payne, W D ^a   Chinnakotla, S ^a   Finger, E B ^a   Sutherland, D E R ^a   Najarian, J S ^a   Pruett, T L ^a   Matas, A J ^a   Kandaswamy, R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Kidney transplantation; rapid discontinuation of prednisone; steroid free immunosuppression

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ANEMIA; ARTICLE; AVASCULAR NECROSIS; BK VIRUS INFECTION; CATARACT; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; FRACTURE; GRAFT SURVIVAL; HEART INFARCTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY INFARCTION; KIDNEY TRANSPLANTATION; LUNG EMBOLISM; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NEUTROPENIA; PNEUMONIA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SKIN CANCER; THROMBOCYTOPENIA;

ADULT; CYCLOSPORINE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; PREDNISONE; PROSPECTIVE STUDIES; SIROLIMUS; STEROIDS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84875740309     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12166     Document Type: Article

References (53)

1. Merrill JP, Murray JE, Harrison JH, Friedman EA, Dealy Jr., JB, Dammin GJ,. Successful homotransplantation of the kidney between nonidentical twins. N Engl J Med 1960; 262: 1251-1260.
2. Murray JE, Merrill JP, Dammin GJ, Dealy JB, Jr., Alexandre GW, Harrison JH,. Kidney transplantation in modified recipients. Ann Surg 1962; 156: 337-355.
3. Merrill JP, Murray JE, Takacs FJ, Hager EB, Wilson RE, Dammin GJ,. Successful transplantation of kidney from a human cadaver. JAMA 1963; 185: 347-353.
4. Murray JE, Merrill JP, Harrison JH, Wilson RE, Dammin GJ,. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 1963; 268: 1315-1323.
5. Briggs WA, Hampers CL, Merrill JP, et al. Aseptic necrosis in the femur after renal transplantation. Ann Surg 1972; 175: 282-289.
6. Morris PJ, Chan L, French ME, Ting A,. Low dose oral prednisolone in renal transplantation. Lancet 1982; 1: 525-527. (Pubitemid 12171520)
7. Tejani A, Butt KM, Rajpoot D, et al. Strategies for optimizing growth in children with kidney transplants. Transplantation 1989; 47: 229-233. (Pubitemid 19069694)
8. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD,. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991; 325: 544-550.
9. Citterio F,. Steroid side effects and their impact on transplantation outcome. Transplantation 2001; 72 (Suppl 12): S75-S80.
10. Vanrenterghem YF, Claes K, Montagnino G, et al. Risk factors for cardiovascular events after successful renal transplantation. Transplantation 2008; 85: 209-216. (Pubitemid 351222383)
11. Prasad GV, Nash MM, McFarlane PA, Zaltzman JS,. Renal transplant recipient attitudes toward steroid use and steroid withdrawal. Clin Transplant 2003; 17: 135-139. (Pubitemid 36833785)
12. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S,. Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374-377. (Pubitemid 20088179)
13. Nevins TE, Kruse L, Skeans MA, Thomas W,. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565-1570. (Pubitemid 32962591)
14. Hricik DE, O'Toole MA, Schulak JA, Herson J,. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 1993; 4: 1300-1305.
15. Kasiske BL, Chakkera HA, Louis TA, Ma JZ,. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910-1917.
16. Ahsan N, Hricik D, Matas A, Rose S, Tomlanovich S, Wilkinson A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil: A prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999; 68: 1865-1874. (Pubitemid 30027339)
17. Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H,. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000; 70: 1352-1359.
18. Pascual J, Quereda C, Zamora J, Hernandez D,. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials. Transplantation 2004; 78: 1548-1556. (Pubitemid 39552943)
19. Pascual J, Quereda C, Zamora J, Hernandez D,. Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Transplant Proc 2005; 37: 3746-3748. (Pubitemid 43015153)
20. Birkeland SA,. Steroid-free immunosuppression in renal transplantation: A long-term follow-up of 100 consecutive patients. Transplantation 2001; 71: 1089-1090.
21. Cole E, Landsberg D, Russell D, et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001; 72: 845-850. (Pubitemid 32879856)
22. Matas AJ, Ramcharan T, Paraskevas S, et al. Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study. Am J Transplant 2001; 1: 278-283. (Pubitemid 33674172)
23. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72: 13-21. (Pubitemid 32652500)
24. Boots JM, Christiaans MH, Van Duijnhoven EM, Van Suylen RJ, Van Hooff JP,. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study. Transplantation 2002; 74: 1703-1709. (Pubitemid 36019323)
25. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M, Roza A,. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 2003; 3: 306-311. (Pubitemid 36407049)
26. Khwaja K, Asolati M, Harmon J, et al. Outcome at 3 years with a prednisone-free maintenance regimen: A single-center experience with 349 kidney transplant recipients. Am J Transplant 2004; 4: 980-987. (Pubitemid 38745597)
27. Matas AJ, Kandaswamy R, Humar A, et al. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 2004; 240: 510-516; discussion 516-517.
28. Matas AJ, Gillingham K, Kandaswamy R, et al. Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone. Transplantation 2009; 87: 100-102.
29. Matas AJ, Kandaswamy R, Gillingham KJ, et al. Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant 2005; 5: 2473-2478.
30. Vitko S, Klinger M, Salmela K, et al. Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: Results of the Atlas study. Transplantation 2005; 80: 1734-1741. (Pubitemid 43053999)
31. Anil Kumar MS, Heifets M, Fyfe B, et al. Comparison of steroid avoidance in tacrolimus/mycophenolate mofetil and tacrolimus/sirolimus combination in kidney transplantation monitored by surveillance biopsy. Transplantation 2005; 80: 807-814. (Pubitemid 41443764)
32. Kumar MS, Xiao SG, Fyfe B, et al. Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies. Clin Transplant 2005; 19: 61-69. (Pubitemid 40227854)
33. Kumar MS, Heifets M, Moritz MJ, et al. Safety and efficacy of steroid withdrawal two days after kidney transplantation: Analysis of results at three years. Transplantation 2006; 81: 832-839.
34. Anil Kumar MS, Irfan Saeed M, Ranganna K, et al. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: Five-year outcomes. Transpl Immunol 2008; 20: 32-42.
35. Montagnino G, Sandrini S, Iorio B, et al. A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. Nephrol Dial Transplant 2008; 23: 707-714. (Pubitemid 351767624)
36. Ferguson R, Grinyo J, Vincenti F, et al. Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant 2011; 11: 66-76.
37. Rizzari MD, Suszynski TM, Gillingham KJ, et al. Ten-year outcome after rapid discontinuation of prednisone in adult kidney transplantation. Clin J Am Soc Nephro. 2012; 7: 494-503.
38. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR,. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996; 98: 2277-2283. (Pubitemid 26394201)
39. Gregory CR, Huang X, Pratt RE, et al. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 1995; 59: 655-661.
40. Kandaswamy R, Melancon JK, Dunn T, et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients: An interim analysis. Am J Transplant 2005; 5: 1529-1536. (Pubitemid 40839448)
41. Humar A, Gillingham K, Kandaswamy R, Payne W, Matas A,. Steroid avoidance regimens: A comparison of outcomes with maintenance steroids versus continued steroid avoidance in recipients having an acute rejection episode. Am J Transplant 2007; 7: 1948-1953. (Pubitemid 47037993)
42. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P,. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Ann Surg 2008; 248: 564-577.
43. Mujtaba MA, Taber TE, Goggins WC, et al. Early steroid withdrawal in repeat kidney transplantation. Clin J Am Soc Nephrol 2011; 6: 404-411.
44. Gallon L, Perico N, Dimitrov BD, et al. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 2006; 6: 1617-1623. (Pubitemid 43945801)
45. Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B,. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 2273-2280. (Pubitemid 41648476)
46. Woodle ES,. A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: One year report. Transplant Proc 2005; 37: 804-808. (Pubitemid 40590707)
47. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS,. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977-983. (Pubitemid 27173021)
48. van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE,. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther Drug Monit 2001; 23: 119-128. (Pubitemid 32240138)
49. Kobayashi M, Saitoh H, Tadano K, Takahashi Y, Hirano T,. Cyclosporin A, but not tacrolimus, inhibits the biliary excretion of mycophenolic acid glucuronide possibly mediated by multidrug resistance-associated protein 2 in rats. J Pharmacol Exp Ther 2004; 309: 1029-1035. (Pubitemid 38669688)
50. Hesselink DA, van Hest RM, Mathot RA, et al. Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant 2005; 5: 987-994. (Pubitemid 40571246)
51. de Fijter JW,. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation. Nephrol Dial Transplant 2007; 22 (Suppl 1): i23-i26.
52. Salgo R, Gossmann J, Schofer H, et al. Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: Reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant 2010; 10: 1385-1393.
53. Alberu J, Pascoe MD, Campistol JM, et al. Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-Month results from the CONVERT trial. Transplantation 2011; 92: 303-310.